Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

tyrosine kinase inhibitor

  • You have access
    Impact of Post-progression Survival on Outcomes of Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma: A Systematic Review and Retrospective Cohort Study
    KAZUTO TAJIRI, YOSHIHARU TOKIMITSU, KENGO KAWAI, YUCHI MOTOFUJI, EIJI SHINNO, YOSHIRO KASHII, NOZOMU MURAISHI, AIKO MURAYAMA, YUKA HAYASHI, MASAMI MINEMURA, TERUMI TAKAHARA, YUKIHIRO SHIMIZU and ICHIRO YASUDA
    Anticancer Research December 2022, 42 (12) 6007-6018; DOI: https://doi.org/10.21873/anticanres.16112
  • You have access
    Efficacy and Safety of Lenvatinib for Patients With Advanced Hepatocellular Carcinoma: A Retrospective, Real-world Study Conducted in Japan
    NAOTAKA SHIMOZATO, TADASHI NAMISAKI, AKIHIRO OKANO, MASAYA OHANA, DAISUKE KINOSHITA, TOSHIHIKO KAWASAKI, YOSUKE AIHARA, TOSHIYA NAKATANI, HIROKI KINOSHITA, TATSUICHI ANN, KO SAITO, MOTOYUKI YOSHIDA and HITOSHI YOSHIJI
    Anticancer Research January 2022, 42 (1) 173-183; DOI: https://doi.org/10.21873/anticanres.15471
  • You have access
    Real-world Outcomes of Tyrosine Kinase Inhibitors Immediately After Immune Checkpoint Inhibitors in Renal Cell Carcinoma
    TAIGO KATO, AKIRA NAGAHARA, NORIHIKO KAWAMURA, WATARU NAKATA, TETSUJI SODA, KYOSUKE MATSUZAKI, KOJI HATANO, ATSUNARI KAWASHIMA, TAKESHI UJIKE, RYOICHI IMAMURA, KENSAKU NISHIMURA, SHINGO TAKADA, MASAO TSUJIHATA, SEIJI YAMAGUCHI, TETSUYA TAKAO, YASUTOMO NAKAI, MASASHI NAKAYAMA, NORIO NONOMURA and MOTOHIDE UEMURA
    Anticancer Research November 2021, 41 (11) 5811-5816; DOI: https://doi.org/10.21873/anticanres.15398
  • You have access
    Targeted Therapy Followed by Cytotoxic Chemotherapy in Preoperative Patients With Locally Advanced Lung Adenocarcinoma
    MASAYA AOKI, KAZUHIRO UEDA, TADASHI UMEHARA, GO KAMIMURA, TAKUYA TOKUNAGA, AYA HARADA-TAKEDA, KOKI MAEDA, TOSHIYUKI NAGATA, NAOYA YOKOMAKURA, KOTA KARIATSUMARI, YUTO NONAKA, NOBUHIRO IMAMURA, SHOICHIRO MORIZONO and MASAMI SATO
    Anticancer Research May 2020, 40 (5) 2911-2916; DOI: https://doi.org/10.21873/anticanres.14268
  • You have access
    Efficacy of Afatinib and Lapatinib Against HER2 Gene-amplified Trastuzumab-sensitive and -resistant Human Gastric Cancer Cells
    SUSUMU NAKATA, MITSUGU FUJITA and HAYAO NAKANISHI
    Anticancer Research November 2019, 39 (11) 5927-5932; DOI: https://doi.org/10.21873/anticanres.13797
  • You have access
    Antiproliferative Effect of Lenvatinib on Human Liver Cancer Cell Lines In Vitro and In Vivo
    SACHIKO OGASAWARA, YUTARO MIHARA, REIICHIRO KONDO, HIRONORI KUSANO, JUN AKIBA and HIROHISA YANO
    Anticancer Research November 2019, 39 (11) 5973-5982; DOI: https://doi.org/10.21873/anticanres.13802
  • You have access
    Neoadjuvant Tyrosine Kinase Inhibition in Locally-advanced Non-small Cell Lung Cancer: Two Cases and a Brief Literature Review
    ANISH B. PARIKH, LINDSAY HAMMONS and JORGE E. GOMEZ
    Anticancer Research February 2019, 39 (2) 897-902; DOI: https://doi.org/10.21873/anticanres.13191
  • You have access
    Prognostic Significance of Pancreatic Metastases from Renal Cell Carcinoma in Patients Treated with Tyrosine Kinase Inhibitors
    PAWEL CHROM, RAFAL STEC, LUBOMIR BODNAR and CEZARY SZCZYLIK
    Anticancer Research January 2018, 38 (1) 359-365;
  • You have access
    Identification of MicroRNAs Involved in Resistance to Sunitinib in Renal Cell Carcinoma Cells
    NORIYA YAMAGUCHI, MITSUHIKO OSAKI, KUNISHIGE ONUMA, TETSUYA YUMIOKA, HIDETO IWAMOTO, TAKEHIRO SEJIMA, HIROYUKI KUGOH, ATSUSHI TAKENAKA and FUTOSHI OKADA
    Anticancer Research June 2017, 37 (6) 2985-2992;
  • You have access
    Increased HGF Expression Induces Resistance to c-MET Tyrosine Kinase Inhibitors in Gastric Cancer
    SO YEONG AHN, JIN KIM, MIN A KIM, JIWOON CHOI and WOO HO KIM
    Anticancer Research March 2017, 37 (3) 1127-1138;

Pages

  • Next
  • 1
  • 2
  • 3
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire